dabigatran has been researched along with Bouillaud Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Eikelboom, JW; Weitz, JI | 1 |
Bett, N; Hamilton-Craig, C; Luis, C; Luis, SA; Poon, K; Shukla, A | 1 |
Otto, CM | 1 |
1 review(s) available for dabigatran and Bouillaud Disease
Article | Year |
---|---|
Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Fibrinolytic Agents; Humans; Pyridones; Rheumatic Heart Disease; Rivaroxaban; Stroke; Vitamin K; Warfarin | 2023 |
2 other study(ies) available for dabigatran and Bouillaud Disease
Article | Year |
---|---|
Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Substitution; Echocardiography; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mitral Valve Stenosis; Rheumatic Heart Disease; Thrombosis; Treatment Outcome; Warfarin | 2013 |
Heartbeat: Echo anytime, anywhere by anyone?
Topics: Antithrombins; Clinical Competence; Dabigatran; Echocardiography; Equipment Design; Heart Valve Diseases; Humans; Lipid Metabolism; Point-of-Care Systems; Point-of-Care Testing; Predictive Value of Tests; Reproducibility of Results; Rheumatic Heart Disease | 2016 |